未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADCCS5001的安全性及有效性：一项全球性I期a/b、首次人体试验研究，该研究针对接受新型抗ROR1 ADC治疗的晚期淋巴瘤患者。
Song, Yuqin; Zhang, Jian; Zhou, Keshu; Zhang, Liling; Barve, Minal; Lemech, Charlotte; Li, Wenyu; Cherng, Hua-Jay J.; Huang, He; Xie, Linna; Zuniga, Richard; Zhou, Caicun; Shen, Lin; Yang, Shujun; Bishnoi, Sarwan; Zhang, Yan; Wang, Jingru; Zhu, Xiaoli; Li, Eei; Yang, Jason 分享 收藏 Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodiesWu, Ercan; Guan, Juan; Yu, Yifei; Lin, Shiqi; Ding, Tianhao; Chu, Yuxiu; Pan, Feng; Liu, Mengyuan; Yang, Yang; Zhang, Zui; Zhang, Jian; Zhan, Changyou; Qian, Jun 分享 收藏 Reciprocal Interaction with Neutrophils Facilitates Cutaneous Accumulation of Liposomes与中性粒细胞的相互作用促进脂质体的皮肤积累Ding, Tianhao; Wang, Yang; Meng, Yanchun; Wu, Ercan; Shao, Qianwen; Lin, Shiqi; Yu, Yifei; Qian, Jun; He, Qin; Zhang, Jian; Wang, Jing; Kohane, Daniel S.; Zhan, Changyou 分享 收藏 分享 收藏 DEA: Data-efficient augmentation for interpretable medical image segmentationWu, Xing; Li, Zhi; Tao, Chenjie; Han, Xianhua; Chen, Yen-Wei; Yao, Junfeng; Zhang, Jian; Sun, Qun; Li, Weimin; Liu, Yue; Guo, Yike 分享 收藏 HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosisLin, Mingxi; Luo, Ting; Jin, Yizi; Zhong, Xiaorong; Zheng, Dan; Zeng, Cheng; Guo, Qing; Wu, Jiong; Shao, Zhi-Ming; Hu, Xichun; Yang, Wentao; Zhang, Jian 分享 收藏 Phase I study of HRS8807, an oral selective ER covalent antagonist (SERCA), in ER+/HER2-locally advanced (LA) or metastatic (M) breast cancer (BC)Wu, J.; Zhang, J.; Meng, Y.; Du, Y.; Liu, X.; Mu, Y.; Zhang, Y.; Wang, J.; Xin, W.; Zhu, X. 分享 收藏 分享 收藏 Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib StudyDalpiciclib联合Pyrotinib和来曲唑治疗HER2-Positive，激素受体阳性转移性乳腺癌 (LORDSHIPS): Ib期研究Zhang, Jian; Meng, Yanchun; Wang, Biyun; Wang, Leiping; Cao, Jun; Tao, Zhonghua; Li, Ting; Yao, Wenqing; Hu, Xichun 分享 收藏 A randomized control phase III trial of entinostat, a once weekly, class I selective histone deacetylase inhibitor, in combination with exemestane in patients with hormone receptor positive advanced breast cancerXu, Binghe; Zhang, Qingyuan; Hu, Xichun; Li, Qing; Sun, Tao; Li, Wei; Ouyang, Quchang; Wang, Jingfen; Tong, Zhongsheng; Yan, Min; Li, Huiping; Zeng, Xiaohua; Shan, Changping; Wang, Xian; Yan, Xi; Zhang, Jian; Zhang, Yue; Wang, Jiani; Zhang, Liang; Lin, Ying; Feng, Jifeng; Chen, Qianjun; Huang, Jian; Lu, Yongkui; Li, Hongsheng; Wu, Jinsheng; Cheng, Jing; Hao, Yanrong; Geng, Cuizhi; Lu, Min; Li, Yanping; Chen, Xi; Song, Lihua; Wu, Xueying; Hu, Changlu; Wu, Xinhong; Wang, Xiaojia; Pan, Yueyin; Cui, Yuehong; Yu, Guohua; Sun, Sanyuan 分享 收藏 分享 收藏 Phase la study of the CDK4/6 inhibitor, FCN-437c, in Chinese patients with HR+/HER2-advanced breast cancerZhang, Jian; Wang, Xiaojia; Wang, Xian; Hui, Aimin; Wu, Zhuli; Tian, Ling; Xu, Changjiang; Yang, Yuchen; Zhang, Wenjing; Hu, Xichun 分享 收藏 A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic CancersZhang, Jian; Yang, Nong; Ji, Dongmei; Shen, Weina; Li, Wenhua; Han, Rubing; Wang, Ning; Tao, Haoxun; Chapman, Sonya C.; Sykes, Amanda K.; Zhang, Wanli; Hu, Xichun 分享 收藏 Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain MetastasesKhan, Muhammad; Arooj, Sumbal; Li, Rong; Tian, Yunhong; Zhang, Jian; Lin, Jie; Liang, Yingying; Xu, Anan; Zheng, Ronghui; Liu, Mengzhong; Yuan, Yawei 分享 收藏 分享 收藏 Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases-a single-center retrospective analysisLi, Zhensheng; Shen, Dongxing; Zhang, Jian; Zhang, Jun; Yang, Fang; Kong, Deyou; Kong, Jie; Zhang, Andu 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
